GLP-1 and Lithium: Toxicity Risk on Ozempic and Zepbound
GLP-1 drugs and lithium are not banned together, and neither label lists the pair as an interaction. But since 2025, at least six published case reports describe lithium levels climbing into the toxic range after people started semaglutide (Ozempic, Wegovy) or tirzepatide (Mounjaro, Zepbound). The likely reasons are less food and fluid, vomiting or diarrhea, and changes in kidney handling, so authors advise checking lithium levels early and after each GLP-1 dose change. Never change either drug on your own; ask your psychiatrist and prescriber for a monitoring plan, and use Sharpy to keep protein and workouts steady while your appetite is low.
Is it safe to take a GLP-1 with lithium? The two are often used together, but lithium levels can rise after a GLP-1 starts, so most experts now say to plan extra blood tests. Since 2025, doctors have published at least six case reports of lithium levels climbing, some to dangerous highs, after people began semaglutide (Ozempic, Wegovy) or tirzepatide (Mounjaro, Zepbound). Neither the GLP-1 labels nor the lithium label names this pair as an interaction yet.
The topic is in the news this week after new tirzepatide case reports were covered by medical outlets. This guide explains what the reports found, why it may happen, and the warning signs. It is not advice for you personally. Never stop, skip or change a dose of lithium or a GLP-1 on your own. People on lithium can become unwell fast if the dose changes without a plan.
GLP-1 and lithium: what the case reports show
Lithium is a mood stabilizer, mostly used for bipolar disorder. Its safe range is narrow. The FDA label for lithium carbonate says toxic levels (1.5 mEq/L or higher) are close to the usual treatment range (0.8 to 1.2 mEq/L). For lithium, mEq/L and mmol/L are the same number.
Here are the published reports we could confirm on PubMed and in journal pages:
| Report | Journal, year | GLP-1 drug | What happened |
|---|---|---|---|
| Al-Soleiti et al., case series | J Clin Psychopharmacol, 2025 | Semaglutide | Lithium toxicity and slower lithium clearance; in one case, lowering lithium early helped, but levels were still higher than expected |
| Onggo et al. | J Clin Psychopharmacol, 2025 | Semaglutide | Lithium toxicity case |
| Burson and Leung | Ment Health Clin, 2026 | Switch from semaglutide to tirzepatide | A 23-year-old developed toxicity soon after the switch |
| Patarroyo-Rodriguez et al. | J Clin Psychopharmacol, 2026 | Tirzepatide | Toxicity that needed hemodialysis in a person who had been stable |
| Patel et al. | Int J Res Med Sci, 2026 | Tirzepatide 10 mg weekly | Level rose from 0.9 to 1.7 mmol/L over about 3 months, with no stomach symptoms |
| Dhingra et al. | Cureus, 2026 | Semaglutide | Lithium held and IV fluids given; kidney function and nerve symptoms recovered |
| Davis et al. | J Clin Psychopharmacol, Oct 2026 | Tirzepatide | Tirzepatide-associated lithium toxicity case |
A 2026 review in International Clinical Psychopharmacology (Cotrik and colleagues) called this "an emerging pharmacovigilance signal." It counted six separate reports published since 2025. A 12-month real-world study of tirzepatide in people on lithium (Rescalli and colleagues, Human Psychopharmacology, 2026) also found two patients with lithium above 1.2 mmol/L.
Case reports cannot tell us how often this happens. Many people take both drugs without trouble. What they do show is that it can happen, sometimes months after starting.
Why GLP-1 drugs may raise lithium levels
Lithium leaves the body almost entirely through the kidneys. Anything that makes the body hold on to salt and water can make it hold on to lithium too. GLP-1 drugs touch that system in a few ways:
- Less food, salt and fluid. Appetite drops, and many people drink less. The lithium label says patients need adequate fluid and warns that dehydration and low sodium raise toxicity risk.
- Vomiting and diarrhea. The lithium label says lower tolerance to lithium has been reported with heavy sweating or diarrhea. Nausea, vomiting and diarrhea are the most common GLP-1 side effects, especially after a dose increase. See our Mounjaro diarrhea guide for how often they happen.
- Kidney stress. The Wegovy label warns of acute kidney injury, mostly in people who had nausea, vomiting or diarrhea leading to fluid loss. Mounjaro and Zepbound carry the same type of warning.
- Slower stomach emptying. GLP-1s delay gastric emptying and may change how oral pills are absorbed. The Wegovy label says semaglutide 1 mg did not change absorption of the oral drugs tested, but still says to monitor oral medicines.
The Patel case stands out because the man was eating and drinking well and had no stomach symptoms. So the cause may not be only dehydration. Researchers say more study is needed.
Ozempic and lithium vs Zepbound and lithium
| Question | Semaglutide (Ozempic, Wegovy, Wegovy pill) | Tirzepatide (Mounjaro, Zepbound) |
|---|---|---|
| Case reports of high lithium? | Yes, from 2025 | Yes, several in 2026 |
| Lithium named in the label? | No | No |
| Label warning on kidney injury from fluid loss? | Yes | Yes |
| Label note on oral drug absorption? | Yes, monitor oral medicines | Yes, mostly about oral birth control |
There is not enough data to say one drug is safer than the other with lithium. The same precautions apply to both. Our guide to Mounjaro and birth control explains the stomach-emptying effect on pills in more detail.
Signs of lithium toxicity to watch for
The lithium label lists early warning signs. Know them before you start a GLP-1:
- A fine shake or tremor in the hands
- Lightheadedness or dizziness
- Clumsiness, poor coordination, trouble walking
- Weakness or feeling very tired
- Nausea, vomiting, diarrhea or bloating
- Confusion or "brain fog"
Some of these look like normal GLP-1 side effects, which is part of the risk. The label also notes symptoms can be delayed up to 24 hours. If you take lithium and feel any of these, call your doctor that day and ask whether you need a lithium level. Get emergency care for severe confusion, a hard time walking, fainting, or nonstop vomiting.
Can you take Ozempic and lithium? Questions for your doctors
The authors of the 2026 tirzepatide case advise "proactive rather than symptom-triggered" lithium checks. Bring these questions to your psychiatrist and to whoever prescribes your GLP-1:
- Do both of you know I am on both drugs?
- When should I get a lithium level and kidney test after starting?
- Should I get another test after each GLP-1 dose increase?
- How much fluid should I aim for each day?
- What should I do if I get vomiting or diarrhea for more than a day?
- Who do I call if I notice a tremor or dizziness?
The lithium label already says to recheck levels after any change in other medicines, so starting a GLP-1 is a natural time for a test. Your mood on a GLP-1 is also worth tracking, since bipolar disorder is listed there as a reason for closer follow-up.
Staying hydrated and fed on a GLP-1 with lithium
Small daily habits lower the fluid and salt swings that matter most for lithium:
- Sip water through the day, even when you are not thirsty. Our hydration on GLP-1 guide has simple targets to discuss with your doctor.
- Do not suddenly cut salt or start a very low-salt diet without asking your psychiatrist. See electrolytes on GLP-1.
- Eat regular small meals, with protein first, so you do not go long stretches with almost no food.
- Take extra care in hot weather, during illness, and after hard workouts, since sweating also affects lithium.
Low appetite makes protein easy to miss, which costs muscle. Sharpy gives you one daily protein target and one 20-minute workout, so you can keep eating enough and stay strong while your doctors handle the lithium checks.
The bottom line
GLP-1 drugs and lithium can be taken together, but a growing number of case reports show lithium levels can climb after semaglutide or tirzepatide starts. Plan lithium and kidney tests with your doctors before you begin and after dose changes, learn the warning signs, and keep fluids steady. For the daily side of life on a GLP-1, Sharpy tracks protein, a short workout and your Shape Score in one place.
Sources
- Lithium carbonate prescribing information (openFDA)
- Wegovy prescribing information (openFDA)
- Patel et al. Lithium toxicity following initiation of tirzepatide in a patient with bipolar I disorder, Int J Res Med Sci 2026
- Al-Soleiti et al. Lithium toxicity and altered clearance following initiation of semaglutide, J Clin Psychopharmacol 2025 (PubMed 40999647)
- Burson and Leung. Lithium toxicity following a change from semaglutide to tirzepatide, Ment Health Clin 2026 (PubMed 41646202)
- Patarroyo-Rodriguez et al. Tirzepatide-associated lithium toxicity necessitating hemodialysis, J Clin Psychopharmacol 2026 (PubMed 42227267)
- Cotrik et al. Lithium and GLP-1-based therapies in bipolar disorder, Int Clin Psychopharmacol 2026 (PubMed 42542974)
- PubMed search: lithium with semaglutide or tirzepatide
Questions people ask
Can you take a GLP-1 and lithium together?
Yes, many people do, and it is not a listed contraindication. The concern is that lithium levels can rise after a GLP-1 starts. Published case authors recommend planned blood tests for lithium and kidney function rather than avoiding the combination. The plan belongs to your psychiatrist and the doctor who prescribes your GLP-1.
Does Ozempic raise lithium levels?
Not in everyone, but there are case reports. A 2025 case series in the Journal of Clinical Psychopharmacology described lithium toxicity and altered lithium clearance after semaglutide was started in patients with bipolar disorder. Ozempic and Wegovy are both semaglutide.
Is there a Zepbound and lithium interaction?
Several 2026 case reports describe lithium toxicity after tirzepatide (Zepbound, Mounjaro) was started, including one case that needed hemodialysis. The Zepbound label does not name lithium, but it warns that vomiting, diarrhea and dehydration can hurt the kidneys, and lithium depends on the kidneys to leave the body.
Why would a GLP-1 cause lithium toxicity?
The exact cause is not proven. Leading ideas are lower food, salt and fluid intake, fluid loss from vomiting or diarrhea, and kidney changes. The lithium label says dehydration, low sodium, heavy sweating and diarrhea can all lower tolerance to lithium. One 2026 case happened with no stomach symptoms at all.
What are the signs of lithium toxicity?
The lithium label lists early signs such as a fine tremor, lightheadedness, poor coordination, weakness, nausea, vomiting and diarrhea. One GLP-1 case presented with brain fog, dizziness and trouble walking. Symptoms can be delayed up to 24 hours. Call your doctor the same day, or get emergency care if symptoms are strong.
How often should lithium be checked on a GLP-1?
There is no official schedule for this pair. The lithium label says to check levels after any change in dose or other medicines. Case authors suggest a lithium level and kidney test within the first few weeks of a GLP-1 and again after each GLP-1 dose increase. Your doctor sets the timing.